miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
详细信息 查看全文
- 作者：Fanfei Kong (1) (2)
Chaoyang Sun (1)
Zhongxian Wang (1)
Lingfei Han (2)
Danhui Weng (1)
Yunping Lu (1)
Gang Chen (1) - 关键词：miR ; 125b ; ovarian cancer ; cisplatin resistance ; Bak1
- 刊名：Journal of Huazhong University of Science and Technology [Medical Sciences]
- 出版年：2011
- 出版时间：August 2011
- 年：2011
- 卷：31
- 期：4
- 页码：543-549
- 全文大小：729KB
- 参考文献：1. Legge F, Ferrandina G, Salutari V, / et al. Biological characterization of ovarian cancer: prognostic and therapeutic implications. Ann Oncol, 2005,16(Suppl 4):iv95-01 CrossRef
2. Reed NS, Sadozye AH. Role of chemotherapy in the management of epithelial ovarian cancer. Expert Rev Anticancer Ther, 2005,5(1):139-47 CrossRef
3. Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer, 2003,3(7):502-16 CrossRef
4. Lai EC. Micro RNAs are complementary to 3-UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet, 2002,30(4):363-64 CrossRef
5. Carninci P, Kasukawa T, Katayama S, / et al. The transcriptional landscape of the mammalian genome. Science, 2005,309(5740):1559-563 CrossRef
6. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell, 2005,122(1):6- CrossRef
7. Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle, 2005,4(9):1179-184 CrossRef
8. Cimmino A, Calin GA, Fabbri M, / et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA, 2005,102(39):13 944-3 949 CrossRef
9. Bandi N, Zbinden S, Gugger M, / et al. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res, 2009,69(13):5553-559 CrossRef
10. Sorrentino A, Liu CG, Addario A, / et al. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol, 2008,111(3):478-86 CrossRef
11. Zhao JJ, Lin J, Yang H, / et al. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem, 2008,283(45):31 079-1 086 CrossRef
12. Fujita Y, Kojima K, Hamada N, / et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun, 2008,377(1): 114-19 CrossRef
13. Iorio MV, Visone R, Di Leva G, / et al. MicroRNA signatures in human ovarian cancer. Cancer Res, 2007,67(18): 8699-707 CrossRef
14. van Jaarsveld MT, Helleman J, Berns EM, / et al. MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol, 2010,42(8):1282-290 CrossRef
15. Ma J, Dong C, Ji C. MicroRNA and drug resistance. Cancer Gene Ther, 2010,17(8):523-31 CrossRef
16. Cuconati A, Mukherjee C, Perez D, / et al. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev, 2003,17(23):2922-932 CrossRef
17. Jones NA, Turner J, McIlwrath AJ, / et al. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Mol Pharmacol, 1998,53(5):819-26
18. Kyrgiou M, Salanti G, Pavlidis N, / et al. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Natl Cancer Inst, 2006,98(22):1655-663 CrossRef
19. Ferrandina G, Zannoni GF, Martinelli E, / et al. Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clin Cancer Res, 2006,12(9):2774-779 CrossRef
20. Zheng T, Wang J, Chen X, / et al. Role of microRNA in anticancer drug resistance. Int J Cancer, 2010,126(1):2-0 CrossRef
21. Kobayashi T, Lu J, Cobb BS, / et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci USA, 2008,105(6):1949-954 CrossRef
22. Huang Q, Gumireddy K, Schrier M, / et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol, 2008,10(2):202-10 CrossRef
23. Yang H, Kong W, He L, / et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res, 2008,68(2):425-33 CrossRef
24. Shi XB, Xue L, Yang J, / et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA, 2007,104(50):19 983-9 988
25. Zhou M, Liu Z, Zhao Y, / et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem, 2010,285(28):21496-1507 CrossRef - 作者单位：Fanfei Kong (1) (2)
Chaoyang Sun (1)
Zhongxian Wang (1)
Lingfei Han (2)
Danhui Weng (1)
Yunping Lu (1)
Gang Chen (1)
1. Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
2. Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 200040, China
文摘